Stocktoria
COGNITION THERAPEUTICS INC CGTX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-08
COGNITION THERAPEUTICS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $37.2M | $41.7M | $37.2M | $30.3M | $18.6M |
| Operating income | -$47.8M | -$54.0M | -$50.7M | -$43.6M | -$28.6M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$23.5M | -$34.0M | -$25.8M | -$21.4M | -$11.7M |
| EPS (diluted) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 |
| Operating cash flow | -$24.6M | -$28.5M | -$16.0M | -$18.5M | -$3.6M |
| Free cash flow | — | -$28.5M | -$16.2M | -$18.7M | -$3.7M |
| Cash & equivalents | $36.8M | $25.0M | $29.9M | $41.6M | $54.7M |
| Total assets | $48.4M | $30.2M | $35.2M | $50.4M | $59.1M |
| Total liabilities | $14.1M | $11.5M | $10.7M | $10.2M | $7.9M |
| Shareholders' equity | $34.3M | $18.8M | $24.5M | $40.2M | $51.3M |
Source: SEC EDGAR filings · CIK 0001455365 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.